Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for inhibiting activation of the human A3 adenosine receptor to treat asthma

Method for inhibiting activation of the human A3 adenosine receptor to treat asthma

US Patent 5780481 · Granted Jul 14, 1998

Estimated economic value: $105,697,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Functionalized N,N-dialkylamino phenyl ethers and their method of use2024
Functionalized N,N-dialkylamino phenyl ethers and their method of use2022
Substituted aryl sulfone derivatives as calcium channel blockers2012
Biaryl substituted pyrazoles as sodium channel blockers2009
Biaryl substituted triazoles as sodium channel blockers2009
Substituted triazoles as sodium channel blockers2008
Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium ch2008
Biaryl substituted triazoles as sodium channel blockers2008
C1 to C4 side chain modified nodulisporic acid analogs2003
Human adenosine receptors2000
Human A3 adenosine receptors1998
Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth ho1998